Background:
Pediatric obesity is closely associated with
cardiometabolic comorbidities, but the role of sex in this relationship is less
investigated. We aimed to evaluate sex-related differences on cardiometabolic
risk factors and preclinical signs of target organ damage in adolescents with
overweight/obesity (OW/OB).
Methods:
The main cross-sectional study
included 988 adolescents (510 boys and 478 girls) with OW/OB aged 10–18 years.
In all youths clinical and biochemical variables were evaluated and an abdominal
echography was performed. Echocardiographic data for the assessment of left
ventricular mass (LVM) and relative wall thickness (RWT) were available in an
independent sample of 142 youths (67 boys and 75 girls), while echographic data
of carotid intima media thickness (cIMT) were available in 107 youths (59 boys
and 48 girls).
Results:
The three samples did not differ for age, body
mass index, and sex distribution. In the main sample, boys showed higher
waist-to-height ratio (WHtR) values (
p
0.0001) and fasting glucose
levels (
p
= 0.002) than girls. Lower levels of estimates glomerular
filtration rate (eGFR) were found in girls vs boys (
p
0.0001). No
sex-related differences for prediabetes and hyperlipidemia were observed. A
higher prevalence of WHtR
0.60 (57.3% vs 49.6%,
p
= 0.016) and
fatty liver disease (FLD) (54.5% vs 38.3%,
p
0.0001) as well as a
trend for high prevalence of hypertension (40.4 vs 34.7%,
p
= 0.06)
were observed in boys vs girls. More, a higher prevalence of mild reduced eGFR
(MReGFR) (
90 mL/min/1.73
) was observed in girls vs boys (14.6% vs
9.6 %,
p
0.0001). In the sample with echocardiographic evaluation,
boys showed higher levels of LVM (
p
= 0.046), and RWT (
p
=
0.003) than girls. Again, in the sample with carotid echography, boys showed
higher levels of cIMT as compared to girls (
p
= 0.011).
Conclusions:
Adolescent boys with OW/OB showed higher risk of abdominal
adiposity, FLD, and increased cardiac and vascular impairment than girls, whereas
the latter had a higher risk of MReGFR. Risk stratification by sex for
cardiometabolic risk factors or preclinical signs of target organ damage should
be considered in youths with OW/OB.